Y-Intercept (HK)’s Veradermics Inc MANE Stock Holding History

Y-Intercept (HK)’s Portfolio MANE Stock Details MANE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$659K	Buy	+5,440	New	+$595K	0.01%	1188

Other funds holding MANE

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return

Fulton Bank Lancaster, Pennsylvania $3.29B AUM 13.65% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

NVWM LLC Yardley, Pennsylvania $533M AUM 27.53% 1-Year Est. Return

Roxbury Financial Mount Arlington, New Jersey $130M AUM 20.04% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Y-Intercept (HK)'s MANE Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in Veradermics Inc (MANE) in Q3 2026: 5,440 shares worth $659K. The stake represents 0.01% of the portfolio and ranks #1188 among its holdings.

19 funds tracked by Wall St. Rank hold MANE as of Q3 2026.

Y-Intercept (HK) held 5,440 shares of Veradermics Inc worth $659K as of Q3 2026.
Veradermics Inc was a new Y-Intercept (HK) position in Q3 2026.
Veradermics Inc made up 0.01% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1188 holding.
19 funds tracked by Wall St. Rank held Veradermics Inc as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.